HeartFlow Analysis vs PMcardio
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you need a non-invasive, detailed 3D model of coronary arteries and their blood flow to diagnose and manage coronary artery disease (CAD). It's particularly well-suited for patients with suspected CAD who may benefit from a precise understanding of blockages and their impact on blood flow, potentially reducing the need for invasive procedures.
View HeartFlow Analysis →Choose PMcardio if…
Choose PMcardio if you require rapid, AI-powered interpretation of ECGs for the assessment of over 50 cardiac conditions, especially in acute or emergency settings. It is ideal for healthcare professionals, including paramedics and ER staff, who need quick, expert-level insights at the point of care to detect critical conditions like STEMI/OMI and guide immediate treatment decisions.
View PMcardio →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | PMcardio |
|---|---|---|
| Pricing | Contact vendor for pricing | Freemium |
| Deployment | Cloud-based (AWS) | Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Pending AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
PMcardioPMcardio offers a mobile app and web platform, allowing for instant AI-powered ECG interpretations at the point of care, which suggests a highly accessible and user-friendly experience for individual clinicians. HeartFlow, while providing a secure web interface for physicians, relies on processing standard CT scans, implying a more centralized and less immediate interaction for the end-user.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis provides a comprehensive, non-invasive solution for diagnosing and managing coronary artery disease by creating personalized 3D models of coronary arteries, FFRct analysis, and plaque analysis, which has been validated in over 200 studies assessing over 365,000 patients. PMcardio focuses on ECG interpretation for over 50 cardiac conditions, with clinical validation in more than 25 studies, but HeartFlow's approach offers a deeper, anatomical and physiological assessment of CAD.
Pricing & Value
PMcardioPMcardio offers a freemium model with a free plan for 5 ECG analyses per month and transparent pricing for Pro plans, making it accessible for individual practitioners and teams. HeartFlow operates on a fee-for-service model, requiring direct contact for pricing, though it is covered by Medicare and most U.S. commercial payers, which may simplify reimbursement for institutions.
Enterprise Readiness
PMcardioPMcardio offers enterprise integrations with EHR/CVIS and EMS systems, SOC 2 Type II, ISO 27001, GDPR, and HIPAA compliance, and localized data residency options, indicating robust enterprise readiness. HeartFlow is cloud-based (AWS) and HIPAA compliant with a BAA, but PMcardio's broader integration capabilities and certifications suggest a more comprehensive enterprise solution.
Innovation
HeartFlow AnalysisHeartFlow's use of AI to create personalized 3D models from CT scans and simulate blood flow (FFRct) to assess the functional significance of coronary artery lesions is a highly innovative approach to non-invasive CAD diagnosis. PMcardio's AI-powered ECG interpretation with visual explainability (ECGxplain) is innovative for ECG analysis, but HeartFlow's 3D modeling and computational fluid dynamics represent a more complex and novel application of AI in cardiology.
Support & Docs
TieBoth tools provide evidence of documentation and support. PMcardio offers a Help Center with user-friendly tutorials and manuals, and regulatory documentation. HeartFlow emphasizes seamless clinical integration and quality-reviewed analyses, suggesting strong support for its institutional users, but specific details on public-facing documentation are less explicit.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | PMcardio |
|---|---|---|
| Tool Name | HeartFlow Analysis | PMcardio |
| Primary Function | Non-invasive diagnosis and management of coronary artery disease (CAD) using AI and 3D models from CT scans. | AI platform for interpreting ECGs to assess over 50 cardiac conditions. |
| Data Input | Standard CT scans (Coronary CT Angiogram - CCTA) | ECGs (12-lead ECGs) |
| Key Outputs/Analyses | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), Roadmapu2122 Analysis for CCTA reading, Computational Fluid Dynamics (CFD) for blood flow simulation. | Instant AI-powered ECG interpretations, Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Queen of Heartsu2122 - STEMI and OMI Detection, LVsenseu2122 - Reduced LVEF Detection, ECGxplainu2122 - Visual AI Explainability with heatmaps, Core AI - Detects 36 core diagnoses, Automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals, Culprit Artery AI confidence scores with 3D heart visualization. |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and PMcardio.
Frequently Asked Questions
More Comparisons
More matchups featuring HeartFlow Analysis or PMcardio
Backers
Who funded each tool's parent company.